LifeStance Health Group Inc (LFST) concluded trading on Thursday at a closing price of $7.68, with 5.77 million shares of worth about $44.28 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.87% during that period and on November 07, 2024 the price saw a gain of about 7.71%. Currently the company’s common shares owned by public are about 378.73M shares, out of which, 110.97M shares are available for trading.
Stock saw a price change of 14.46% in past 5 days and over the past one month there was a price change of 11.47%. Year-to-date (YTD), LFST shares are showing a performance of -1.92% which increased to 23.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.64 but also hit the highest price of $9.20 during that period. The average intraday trading volume for LifeStance Health Group Inc shares is 1.41 million. The stock is currently trading 9.40% above its 20-day simple moving average (SMA20), while that difference is up 11.29% for SMA50 and it goes to 22.24% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
LifeStance Health Group Inc (NASDAQ: LFST) currently have 378.73M outstanding shares and institutions hold larger chunk of about 32.77% of that.
The stock has a current market capitalization of $2.94B and its 3Y-monthly beta is at 1.25. It has posted earnings per share of -$0.25 in the same period. It has Quick Ratio of 1.22 while making debt-to-equity ratio of 0.34. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LFST, volatility over the week remained 5.91% while standing at 4.18% over the month.
Stock’s fiscal year EPS is expected to rise by 55.38% while it is estimated to increase by 23.76% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barclays on January 03, 2024 offering an Underweight rating for the stock and assigned a target price of $7 to it. Coverage by TD Cowen stated LifeStance Health Group Inc (LFST) stock as a Market perform in their note to investors on May 15, 2023, suggesting a price target of $9 for the stock. On January 06, 2023, Morgan Stanley Upgrade their recommendations, while on November 07, 2022, Jefferies Resumed their ratings for the stock with a price target of $7.25. Stock get a Neutral rating from UBS on March 17, 2022.
